Menaril 16 Tablet

Betahistine Dihydrochloride
16 mg
Incepta Pharmaceuticals Ltd.
Pack size50's Pack
Retail Price5.00

Indications

Meniere's disease, tinnitus and/or progressive loss of hearing, vertigo, dizziness.

Adult Dose

Adult: Initially, 8-16 mg tid. Maintenance: 24-48 mg daily.

Administration

Should be taken with food.

Contra Indications

Phaeochromocytoma. Porphyria.

Precautions

Active peptic ulcer, bronchial asthma, pregnancy and lactation.

Pregnancy-Lactation

C

Interactions

May antagonise antihistamines. May decrease bronchodilator effects of beta-2 agonists.

Adverse Effects

Rash, pruritus, urticaria, dyspepsia, nausea, peptic ulcer disease, headache, dizziness, insomnia.

Mechanism of Action

Betahistine improves the microcirculation in the labyrinth which reduces endolymphatic pressure.

Note

Menaril 16 16 mg Tablet manufactured by Incepta Pharmaceuticals Ltd.. Its generic name is Betahistine Dihydrochloride.

Some other brands of Betahistine Dihydrochloride